Axon Neuroscience's active tau immunotherapy AADvac1 has been selected as the first tau-targeted therapy to enter a ...
Forty-Hz auditory stimulation increased amyloid clearance markers in aged primates and produced lasting effects, supporting its potential as a non-invasive Alzheimer’s therapy. Scientists at the Kunmi ...
The country is facing a coming wave of dementia for its ageing population, and is investing in research into drugs, ...
A new blood test could predict when Alzheimer’s will strike — years before symptoms begin. Scientists at Washington University School of Medicine in St. Louis have created a way to estimate when a ...
Science’s success at staving off death from heart disease or cancer has made another diagnosis more likely: Dementia.
Mandara Biopharma Inc. announced approval from the FDA to initiate their clinical trials for the treatment of agitation ...
The technique is not yet precise enough to predict a patient’s exact trajectory but could help find long-sought preventive treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results